The research and development of new active ingredients could be significantly improved by AI.
(Photo: Bloomberg)
Frankfurt, Dusseldorf An average of ten to twelve years – that’s how long it takes for a new drug to be developed. Clinical trials in which a drug candidate is tested on patient groups account for seven years of this. On average, it costs more than two billion euros to bring a drug to market.
What if you could cut costs? Accelerate development? Getting medicines to patients faster? This is exactly what pharmaceutical companies hope to achieve from the use of artificial intelligence (AI). And the first projects have got off to a promising start.
Up to 70 percent of time and money could be saved, Ashwini Ghogare predicted at the beginning of the year at the World Economic Forum in Davos. The chemist heads the AI and Automation in Drug Discovery department at the Merck subsidiary MilliporeSigma. “Artificial intelligence offers enormous potential for discovering new and more effective medicines,” she says. “In this way, better therapies can become available to patients more quickly.”
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further
Read on now
Get access to this and every other article in the
web and in our app.
Further